Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
23.88
+0.37 (1.57%)
At close: Aug 21, 2026, 4:00 PM EDT
24.02
+0.14 (0.59%)
After-hours: Aug 21, 2026, 7:45 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $4.03 billion as of August 21, 2026. Its market cap has increased by 436.14% in one year.
Market Cap
4.03B
Enterprise Value
3.04B
1-Year Change
436.14%
Ranking
Category
Stock Price
$23.88
ChartMarket Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $4.03B, an increase of 2,475.98%. That is a compound annual growth rate of 83.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 4.03B | 237.44% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 4.38B |
| Veradermics | 4.30B |
| Relay Therapeutics | 4.26B |
| Legend Biotech | 4.23B |
| Denali Therapeutics | 3.98B |
| Viking Therapeutics | 3.95B |
| Arcus Biosciences | 3.86B |
| IDEAYA Biosciences | 3.83B |